ES
12
3
HBAN
47
7
GS
65
16
RL
73
5
DUK
49
4
HSIC
42
2
APH
53
3
KMI
69
8
KLAC
45
3
JCI
44
7
BDX
59
3
AAPL
64
3
EQR
33
6
EXPE
83
8
SPG
45
2
SYK
50
4
CI
35
2
LNC
28
3
ALL
37
3
L
54
5
ES
12
3
HBAN
47
7
GS
65
16
RL
73
5
DUK
49
4
HSIC
42
2
APH
53
3
KMI
69
8
KLAC
45
3
JCI
44
7
BDX
59
3
AAPL
64
3
EQR
33
6
EXPE
83
8
SPG
45
2
SYK
50
4
CI
35
2
LNC
28
3
ALL
37
3
L
54
5
Financhill
Back

Roche Holding AG Quote, Financials, Valuation and Earnings

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
43

RHHBY
Roche Holding AG

Last Price:
$34.50
Seasonality Move:
-3.58%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

Roche Holding AG Price Quote

$34.50

Roche Holding AG Key Stats

Sell
43
Roche Holding AG (RHHBY) is a Sell
Day range:
$34.29 - $34.67
52-week range:
$29.20 - $42.43
Dividend yield:
3.91%
P/E ratio:
17.32
P/S ratio:
3.28
P/B ratio:
6.83%
Volume:
1.3M
Avg. volume:
1.1M
1-year change:
-1.46%
Market cap:
$219.9B
Revenue:
$67.3B
EPS:
$1.85

How Much Does Roche Holding AG Make?

Data Unavailable

Is Roche Holding AG Growing As A Company?

Data Unavailable

Roche Holding AG Stock Price Performance

What Is Roche Holding AG 52-Week High & Low?

Roche Holding AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Roche Holding AG?

Data Unavailable

Is Roche Holding AG Cash Flow Positive?

Data Unavailable

Roche Holding AG Return On Invested Capital

Data Unavailable

Roche Holding AG Earnings Date & Stock Price

Roche Holding AG Competitors

  • Who Are Roche Holding AG's Competitors?
    Below is a list of companies who compete with Roche Holding AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • NLS Pharmaceutics Ltd (NLSP)
    • Pfizer Inc (PFE)

Roche Holding AG Dividend Yield

Data Unavailable

Roche Holding AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 1.49%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 4
Sell Recommendations: 1
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable